Payment Policy Update: Beginning September 1, 2026, Virginia Cancer Specialists will no longer accept cash. Read more here..

A chemotherapy regimen consisting of cyclophosphamide, methotrexate, and fluorouracil, which may be used in the adjuvant setting for the treatment of nonmetastatic breast cancer or alone for the treatment of metastatic breast cancer. (NCI Thesaurus)

Related Posts

Recent Posts

Payment Policy Update: Virginia Cancer Specialists Will No Longer Accept Cash
Payment Policy Update: Virginia Cancer Specialists Will No Longer Accept Cash
August 18, 2026
Read More
Nationally Recognized Lung Cancer Researcher and ASCO Young Investigator Award Honoree, Tina Roy, MD, Joins the Physician Team at Virginia Cancer Specialists
Nationally Recognized Lung Cancer Researcher and ASCO Young Investigator Award Honoree, Tina Roy, MD, Joins the Physician Team at Virginia Cancer Specialists
August 18, 2026
Read More
Join Team Virginia Cancer Specialists at the 2026 MMRF Washington, D.C. Walk
Join Team Virginia Cancer Specialists at the 2026 MMRF Washington, D.C. Walk
August 12, 2026
Read More
Virginia Cancer Specialists Welcomes Medical Oncologist Ellery Altshuler, MD, to Fairfax
Virginia Cancer Specialists Welcomes Medical Oncologist Ellery Altshuler, MD, to Fairfax
August 12, 2026
Read More
Virginia Cancer Specialists Clinical Research Leader Receives SCRI Site Partnership Excellence Award
Virginia Cancer Specialists Clinical Research Leader Receives SCRI Site Partnership Excellence Award
August 4, 2026
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top